Navigation Links
Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA
Date:9/1/2010

Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA -- CASTRES, France, September 1, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Personnel Announcements Click to view news release full screen  

Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA

 

CASTRES, France, September 1, 2010 /PRNewswire/ -- During its first meeting, the Board of Directors of Pierre Fabre SA chaired by Mr. Pierre Fabre appointed Olivier BOHUON as the company's Chief Executive Officer.

Olivier BOHUON, 51, has until now been the executive vice-president of Abbott Corporation and president of its pharmaceutics division. In this capacity, he directed the group's entire pharmaceutical business (22 billion dollars turnover) from Chicago. He also became group president for Europe in 2003 and subsequently president of Abbott international.

Olivier BOHUON has also been appointed president of Pierre Fabre Medicament as of today.

About the Pierre Fabre group

The Pierre Fabre group, owned on a majority basis by a public utility Foundation, is France's second largest independent pharmaceutics laboratory and the leader in cosmetics products sold in pharmacies.

It employs a workforce of nearly 10,000 including 1,400 in research.

In 2009, the Pierre Fabre group achieved a turnover of 1.8 billion EUR and dedicated 28% of its medical turnover to research and development in three main therapeutic areas: oncology, central nervous system, dermatology and cardio-vascular/metabolism.

To find out more about Laboratoires Pierre Fabre : http://www.pierre-fabre.com


'/>"/>
SOURCE Groupe Pierre Fabre
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Olivier Bohuon Joins Pierre Fabre
2. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
3. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
4. Robert Cantu Appointed Vice President of Pierpoint International
5. Timothy I. Still Appointed CEO at Accumetrics
6. Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
7. Paul Keim Appointed to febits Scientific Advisory Board
8. Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences
9. Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
10. FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout
11. Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN DIEGO , Feb. 23, 2017 /PRNewswire/ ... protein research tools, announced the acquisition of GenWay ... with a comprehensive service and product offering for ... "This acquisition will facilitate growth and enhance capabilities ... proteins, antibodies, and ELISA assays will nicely complement ...
(Date:2/22/2017)... , Feb. 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: ... and commercialization of innovative biopharmaceutical products for companion animals, will ... at 8:30 a.m. ET to discuss financial results from the ... Interested participants and investors may access the ... ...
(Date:2/22/2017)... 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today its ... the Annual Biocom Global Life Science Partnering Conference.  The ... AM, at the Torrey Pines Lodge, in San Diego.  ... at Biocom who have chosen our company, amongst numerous ... companies, investors, and clinical researchers," said Mr. Chen. "In ...
(Date:2/22/2017)... Toronto, ON (PRWEB) , ... February 22, 2017 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... trials validate the ProMIS approach.” This is one of a series of commentaries ...
Breaking Biology Technology:
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
Breaking Biology News(10 mins):